HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hittu Matta Selected Research

isocarbostyril

1/2020Narciclasine, an isocarbostyril alkaloid, has preferential activity against primary effusion lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hittu Matta Research Topics

Disease

6Primary Effusion Lymphoma
01/2020 - 01/2005
5Neoplasms (Cancer)
11/2021 - 10/2002
5Infections
08/2009 - 03/2003
3Kaposi Sarcoma (Kaposi's Sarcoma)
09/2013 - 02/2005
3Lymphoma (Lymphomas)
11/2010 - 06/2004
2Hematologic Neoplasms (Hematological Malignancy)
01/2019 - 01/2005
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
02/2013 - 09/2005
1Dermatitis
01/2012
1Inflammation (Inflammations)
01/2012
1Disease Progression
08/2011
1Plasmacytoma
08/2011
1T-Cell Leukemia (Leukemia, T Cell)
08/2011
1Breast Neoplasms (Breast Cancer)
02/2010
1Ectodermal Dysplasia (Aplasia Cutis Congenita)
02/2010
1Virus Diseases (Viral Diseases)
08/2009
1Carcinogenesis
10/2007
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2005
1Multiple Myeloma
01/2005
1Leukemia
03/2003
1Lung Neoplasms (Lung Cancer)
12/2002
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2002

Drug/Important Bio-Agent (IBA)

7NF-kappa B (NF-kB)IBA
08/2011 - 03/2003
4CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA
06/2011 - 02/2005
3Proteins (Proteins, Gene)FDA Link
08/2009 - 02/2005
3Caspase 8 (Caspase-8)IBA
09/2005 - 10/2002
3Death Domain ReceptorsIBA
12/2002 - 10/2002
2CytokinesIBA
01/2012 - 08/2009
2DNA (Deoxyribonucleic Acid)IBA
01/2012 - 02/2010
1AlkaloidsIBA
01/2020
1narciclasineIBA
01/2020
1isocarbostyrilIBA
01/2020
1Chimeric Antigen ReceptorsIBA
01/2019
1purineIBA
09/2013
16- chloro- 9- (4- methoxy- 3,5- dimethylpyridin- 2- ylmethyl)- 9H- purin- 2- ylamineIBA
09/2013
1anti-IgMIBA
02/2013
1Transcription Factors (Transcription Factor)IBA
01/2012
1sharpinIBA
01/2012
1TNF Receptor-Associated Factor 6 (TRAF6)IBA
01/2012
1ruxolitinibIBA
08/2011
1Janus Kinase InhibitorsIBA
08/2011
1Dexamethasone (Maxidex)FDA LinkGeneric
08/2011
1Interleukin-6 (Interleukin 6)IBA
08/2011
1tax Gene Products (tax Gene Product)IBA
08/2011
1DecitabineFDA Link
02/2010
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
02/2010
1Xedar ReceptorIBA
02/2010
1ChemokinesIBA
08/2009
1Chemotactic FactorsIBA
05/2009
1Chemokine CCL20IBA
05/2009
1Oncogene Proteins (Oncogene Protein)IBA
08/2007
1EnzymesIBA
09/2005
1Viral ProteinsIBA
09/2005
1Antigen Receptors (Antigen Receptor)IBA
09/2005
1tat Gene Products (tat Protein)IBA
02/2005
1Caspase 1 (ICE Protease)IBA
02/2005
1Proteasome InhibitorsIBA
01/2005
1Bortezomib (Velcade)FDA Link
01/2005
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2003
1LigandsIBA
12/2002

Therapy/Procedure

2Immunotherapy
11/2021 - 01/2019
2Drug Therapy (Chemotherapy)
09/2013 - 11/2002
1Therapeutics
11/2002